Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 210629
Company: LUPIN
Company: LUPIN
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
CYANOCOBALAMIN | CYANOCOBALAMIN | 0.5MG/SPRAY | SPRAY, METERED;NASAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
06/30/2023 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
CYANOCOBALAMIN
SPRAY, METERED;NASAL; 0.5MG/SPRAY
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
CYANOCOBALAMIN | CYANOCOBALAMIN | 0.5MG/SPRAY | SPRAY, METERED;NASAL | Prescription | No | AB | 210629 | LUPIN |
CYANOCOBALAMIN | CYANOCOBALAMIN | 0.5MG/SPRAY | SPRAY, METERED;NASAL | Prescription | No | AB | 212458 | PADAGIS ISRAEL |
NASCOBAL | CYANOCOBALAMIN | 0.5MG/SPRAY | SPRAY, METERED;NASAL | Prescription | Yes | AB | 021642 | ENDO PHARMS INC |